您的当前位置:首页 > 行业数据 > 诺诚健华以奥布替尼为核心,已布局具备高度差异化竞争优势及协同效应的血液瘤在研管线
图片属性
图片格式:PNG 图片大小:262KB 图片尺寸:2327*1073
同报告图片
 / 4
诺诚健华以奥布替尼为核心,已布局具备高度差异化竞争优势及协同效应的血液瘤在研管线_第1页
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
诺诚健华以奥布替尼为核心,已布局具备高度差异化竞争优势及协同效应的血液瘤在研管线_第2页
诺诚健华以奥布替尼为核心,已布局具备高度差异化竞争优势及协同效应的血液瘤在研管线_第3页
诺诚健华以奥布替尼为核心,已布局具备高度差异化竞争优势及协同效应的血液瘤在研管线_第4页
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
诺诚健华以奥布替尼为核心,已布局具备高度差异化竞争优势及协同效应的血液瘤在研管线_第5页
所属报告: 医药生物行业深度报告:血液瘤创新技术层出各亚型均有孵化“重磅炸弹”药物潜力-241224(52页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠